收藏切换
The research progress of PROTACs for breast cancer treatment
收藏切换
PDF
Bao-hua XIE1, Zhi-ye HU1, Wen-tao NING1, Lu YANG2, 3, Hai-bing ZHOU1, 3, *
Acta Pharmaceutica Sinica | 2020, 55(9) : 2053 - 2061
Less
收藏切换
Acta Pharmaceutica Sinica | 2020, 55(9): 2053-2061
Reviews
The research progress of PROTACs for breast cancer treatment
Full
Bao-hua XIE1, Zhi-ye HU1, Wen-tao NING1, Lu YANG2, 3, Hai-bing ZHOU1, 3, *
Affiliations
  • 1. Hubei Province Engineering and Technology Research Centre for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China
  • 2. Radiological Molecular Imaging Laboratory, Department of Radiology, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
  • 3. The State Key Laboratory of Virology, Wuhan 430072, China
Published: 2020-09-12 doi: 10.16438/j.0513-4870.2020-0340
Outline
收藏切换

Breast cancer is the most common malignant tumor in women worldwide. In breast cancer tumor tissues, a variety of targets related to the occurrence and development of breast cancer have been observed, and many drugs have been used in clinical applications for these targets. However, most of these drugs are small molecule inhibitors. With the long-term use of these drugs, acquired drug resistance often occurs in breast cancer patients. To overcome the drug resistance, the development of more efficient drugs is highly desirable in the treatment of breast cancer. Proteolysis targeting chimera (PROTAC) technology is a new kind of targeted protein degradation technology, which has shown broad prospect of applications in the field of drug development. The use of PROTAC technology to target the degradation of relevant targets in breast cancer has become a feasible strategy for breast cancer treatment.

breast cancer  /  target  /  drug resistance  /  PROTACs
Bao-hua XIE, Zhi-ye HU, Wen-tao NING, Lu YANG, Hai-bing ZHOU. The research progress of PROTACs for breast cancer treatment[J]. Acta Pharmaceutica Sinica, 2020 , 55 (9) : 2053 -2061 . DOI: 10.16438/j.0513-4870.2020-0340
Year 2020 volume 55 Issue 9
PDF
143
60
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2020-0340
  • Receive Date:2020-03-17
  • Online Date:2026-01-23
  • Published:2020-09-12
Article Data
Affiliations
History
  • Received:2020-03-17
  • Revised:2020-04-10
Funding
Affiliations
    1. Hubei Province Engineering and Technology Research Centre for Fluorinated Pharmaceuticals, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China
    2. Radiological Molecular Imaging Laboratory, Department of Radiology, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
    3. The State Key Laboratory of Virology, Wuhan 430072, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2020-0340
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT